Skip to content
Apply
Stories

Are COVID-19 vaccine trials ethical?

People in this story

Photo by Matthew Modoono/Northeastern University

As the race to create a COVID-19 vaccine speeds ahead, many people have expressed an unwillingness to receive the immunization once it’s available, arguing that the vaccine won’t have enough time to undergo proper vetting. Now, researchers fear that some of those same people won’t be interested in participating in vaccine clinical trials, illuminating a tricky catch-22—people don’t want a vaccine unless it’s been tested, but people also don’t want to be part of the tests because of the unknown risks. 

Suspicions about the vaccine development process were reinforced last week following the death of a Brazilian volunteer in an experimental trial for a COVID-19 vaccine developed by Oxford University, and produced by the pharmaceutical company AstraZeneca.  While it’s unclear whether the participant’s death was linked to the trial, the incident nonetheless sowed doubt among an already dubious section of the population, as reflected in the subsequent downturn in AstraZeneca shares

Continue reading at News@Northeastern.

More Stories

U.S. Supreme Court Justice Sandra Day O'Connor hold up a copy of the U.S. constitution that she carries with her Saturday, Sept. 17, 2005 at an open-air Immigration and Naturalization citizenship hearing in Gilbert, Ariz.

Sandra Day O’Connor, first woman to serve on the Supreme Court, remembered as “independent thinker” who often disappointed conservatives

12.04.2023
Denise Garcia’s, book, The AI Military Race, on Nov. 30, 2023.

Military AI: New book anticipates a world of “killer robots”—and the need to regulate them

12.04.2023
A hand grazes a bunch of purple grapes at a winery.

Northeastern grad helps breathe new life into family’s Rhode Island vineyard

12.05.23
Student Stories